Home » Topics » Briefs » Other news to note

Other news to note
RSS

C4X Discovery Holdings and e-therapeutics collaboration meets success

Dec. 10, 2018

Seres Therapeutics initiates phase II study of SER-287 in ulcerative colitis

Dec. 10, 2018

Carnot Biosciences and HemoShear Therapeutics to develop protein-based therapeutics

Dec. 5, 2018

Adynxx and twoXAR aim to discover new treatments for endometriosis

Nov. 16, 2018

U.S. Rare Earth Minerals changes name to Bioxytran

Nov. 15, 2018

Hemostemix develops ACP-01 allogeneic process, begins R&D for NCP-01

Nov. 13, 2018

Denali and Sanofi collaborate to develop RIPK1 inhibitors

Nov. 6, 2018

Adverum discontinues development of ADVM-043, advances ADVM-022

Nov. 2, 2018

Cytokinetics announces new cardiovascular candidates and updates pipeline progress

Oct. 18, 2018

Boston expands pipeline through licensing deals with Novartis and GSK

Oct. 4, 2018

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...